PUBLISHER: DataM Intelligence | PRODUCT CODE: 1529398
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1529398
Overview
The China contact lenses market reached US$ 577.9 million in 2023 and is expected to reach US$ 1118.2 million by 2031, growing at a CAGR of 8.6% during the forecast period 2024-2031.
A contact lens is a small, curved lens that rests over the tear film and covers the cornea of the eye. Contact lenses, like spectacles, are used to treat refractive issues that impact vision. Even though contact lenses are initially clear, the tiniest hint of color is frequently utilized to match the wearers' natural eye color.
Contact lenses are thin, curved lenses placed on the surface of the eye to correct vision problems such as myopia, hyperopia, astigmatism, and presbyopia. The market is driven by factors such as the driven by factors such as rising prevalence of myopia, increasing awareness and adoption of contact lenses, and government initiatives to promote eye health.
Market Dynamics: Drivers
Rising prevalence of myopia
The demand for the China contact lenses market is driven by multiple factors. The prevalence of myopia in China has gradually increased over the last few decades due to a change in lifestyle over time. According to a Nature publication in June 2023, the prevalence of myopia rises steeply from 2-4% when children start school to around 80% by the end of 12 years of school.
Childhood myopia may lead to serious eye diseases, potentially causing irreversible blindness later in life. Low, moderate, and high myopia are all associated with serious eye diseases, such as myopic macular degeneration (MMD), retinal detachment (RD), cataracts, and open-angle glaucoma (OAG). The likelihood of developing complications related to myopia increases with the severity of myopia.
The Chinese government has launched several initiatives to promote eye health and reduce the prevalence of myopia among children. This has led to increased awareness and adoption of contact lenses as a preventive measure. According to an NCBI publication in April 2024, the Chinese government has undertaken a series of measures at the national level, including education reforms, programs aimed at improving parents' awareness, and application-approved interventions to combat the myopia epidemic.
Similarly, in October 2023, BCLA Asia, organized by the British Contact Lens Association (BCLA) in conjunction with the West China International Myopia Control and Eye Care Symposium, will cover topics including myopia control, dry eye management, contact lens care, and specialty lenses.
High cost of the lenses
The high costs of the lenses, availability of inferior and knockoff products, patient discomfort, regulatory framework, limited healthcare infrastructure, and quality control issues are expected to hamper the market.
For more details on this report - Request for Sample
The China contact lenses market is segmented based on type, design, duration of wear, application, and distribution channel.
The soft contact lenses segment accounted for approximately 81.5% of the China contact lenses market share
The soft contact lenses segment is expected to hold the largest market share over the forecast period. The rising prevalence of myopia, especially among younger generations, has driven the demand for soft contact lenses in China. Soft contact lenses are more comfortable to wear for extended periods compared to gas-permeable lenses.
Moreover, China's regulatory framework regarding soft contact lenses and product launches & approvals would propel this segment growth in China. According to the Chinese National Medical Products Administration (NMPA), in June 2024, which is in charge of overseeing compliance with its regulatory framework, contact lenses as a class III medical device and requires receiving a registration certificate from the NMPA. Additionally, in China, practitioners can fit soft lenses in eye clinics, local hospitals, or optical store outlets.
For instance, in August 2022, The Chinese National Medical Products Administration (NMPA), which regulates medical devices and pharmaceuticals, approved Cooper Vision MiSight 1-day contact lenses for use within the country following a priority review. The innovative soft contact lenses have now become the first indicated product of any type in China that may slow the progression of axial length.
The U.S. FDA-approved soft contact lens is designed for myopia control with a proven ability to slow the progression of nearsightedness in children aged 8-12 at the initiation of treatment. The lenses serve as the foundation for the company's Brilliant Futures Myopia Management Program, which is available in select countries around the world.
Also, in April 2022, Johnson & Johnson Vision announced the launch of the Abiliti brand in Hong Kong - a powerful new comprehensive approach to myopia management designed to help parents control their children's myopia progression. The first-of-its-kind solution suite comprising of an overnight ortho-k therapeutic lens, a 1-day soft therapeutic lens, and the SeeAbiliti digital app, a personalized digital companion, provides safe options to help reduce the risk of myopia-related eye health threats and support better vision management.
By Type
By Design
The major players in the China contact lenses market include Alcon (China) Ophthalmic Product Co Ltd, Johnson & Johnson Services, Inc, Menicon Co., Ltd, CooperVision, Changzhou Jingli Optical Technology Co., Ltd, Shenzhen Dasicheng Optical Technology Co., Ltd, Jilin Realcon Contact Lens Co., Ltd, Gansu Constar Technology Group, Bausch + Lomb and Ecoptik among others.
The China contact lenses market report would provide approximately 45 tables, 39 figures, and 176 Pages.
Target Audience 2024
LIST NOT EXHAUSTIVE